D-2HG also inhibits the branched-chain amino acid transaminase 1 (BCAT1) and 2 (BCAT2), which renders IDH1 mutant glioma cells dependent on glutaminase and increases their sensitivity to oxidative stress [151]. The gene discussed is BCAT1; the disease is glioma.